LifeMD, Inc.
LFMD
$3.84
-$0.09-2.29%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.53% | -6.99% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.53% | -6.99% | |||
| Cost of Revenue | -0.31% | -14.03% | |||
| Gross Profit | -1.69% | -5.92% | |||
| SG&A Expenses | -2.05% | 1.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.16% | 26.19% | |||
| Total Operating Expenses | -1.56% | -0.05% | |||
| Operating Income | 2.52% | -179.44% | |||
| Income Before Tax | -26.25% | -240.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -32.55% | -240.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 50.60% | 5.02% | |||
| Net Income | -19.38% | -330.23% | |||
| EBIT | 2.52% | -179.44% | |||
| EBITDA | 8.73% | -153.37% | |||
| EPS Basic | -11.32% | -732.62% | |||
| Normalized Basic EPS | 27.49% | -418.83% | |||
| EPS Diluted | -12.11% | -992.00% | |||
| Normalized Diluted EPS | 27.49% | -436.30% | |||
| Average Basic Shares Outstanding | 3.90% | 3.00% | |||
| Average Diluted Shares Outstanding | 3.90% | -2.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 0.16% | -1.43% | |||